India Cuts Back Vaccine Exports
With
its own battle against the coronavirus taking a sharp turn for the worse, the
Indian government is now
holding back nearly all of the 2.4 million doses that
its biggest vaccine producer, the Serum Institute of India, puts out each day.
More
than 70 countries have received vaccines made in India, especially the
AstraZeneca shot. But as a second wave hits home, India is drawing up its
gates: The size of its shipments abroad has greatly diminished in the past two
weeks, according to data from the foreign ministry.
Slowing
exports could derail the world’s vaccination drive: Covax,
the global initiative many low-income countries are relying on, warned of
delays because of increased demand in India. Production issues at AstraZeneca
facilities in Europe have led a host of countries to rely on the Serum
Institute, making the company even more critical to the global vaccine supply
chain.
Awkward
spot: The Serum Institute has an interest in fulfilling the contracts it
has signed with foreign countries. Its chief executive has been careful not to
say anything negative about the pressure Prime Minister Narendra Modi is
putting on him.
The
numbers: India is desperate for all of the doses it can get. Infections are
soaring, topping 50,000 per day, more than double the number less than two
weeks ago. The country’s vaccination drive has been sluggish, with less than 4
percent of India’s nearly 1.4 billion people getting a jab.
In
other developments:
·
AstraZeneca released new data reaffirming that
its vaccine
was highly effective at preventing Covid-19. The findings, showing
a 76 percent efficacy rate, strengthen its scientific case but may not repair
damage to its public image.
·
Papua New Guinea is facing a
major virus surge, after months of no infections. The island
nation has reported more than 4,100 cases, and 39 virus-related deaths, the
vast majority of them since mid-February.
·
President Biden doubled the vaccine goal for
his first 100 days in office to 200
million shots. The nation is on track to meet that goal.